Procedures appropriate to meet core CGTP requirements for all steps that you perform in the manufacture of HCT/Ps were not defined and followed.
Inspection Record
MD Tox Laboratory — FDA 483 Findings
Inspectors Celeta S CovesThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
A records management system relating to core CGTP requirements was not maintained and documented.
A quality program which addresses all of the core CGTP requirements, appropriate for the HCT/Ps manufactured and the manufacturing steps performed, has not been defined and followed.
Records were not retained for the appropriate length of time, 10 years after their creation.
Records were not detailed as necessary to provide a complete history of work performed.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Musculoskeletal Transplant Foundation2015-07-23 · US FDASimilar to finding 1 Procedures appropriate to meet core CGTP requirements for all steps that you perform in the manufacture of HCT/Ps were not followed.
- Nelson Laboratories, LLC2025-07-30 · US FDASimilar to finding 5 Records were not detailed as necessary to provide a complete history of work performed.
A record as of the US FDA document published on 2026-10-27. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.